Drugs Made In America Acquisition Ii CorpDrugs Made In America Acquisition Ii Corp
Drugs Made In America Acquisition Ii Corp

Drugs Made In America Acquisition Ii Corp

DMII
Industrials·Shell Companies

Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in New York, NY.

Florida; U.S.A
Market cap
No dataNo data
Revenue
$0No data
Net income
No dataNo data
Free cash flow
$-1MNo data

Market

Listed stock
DMIIPriceNasdaq
Loading…Loading…1Y

Financial performance

Revenue
$0No data
Operating income
$-488.4KNo data
Net income
No dataNo data
Free cash flow
$-1MNo data

Revenue, profit & cash trend

No data

Growth & profitability

Revenue growth
No dataNo data
Gross margin
No dataNo data
Operating margin
No dataNo data
FCF margin
No dataNo data

Earnings power over time

No data

Growth heatmap

No dataCAGR
RevenueNo data
No data
Gross profitNo data
No data
Operating incomeNo data
No data
Free cash flowNo data
No data

Earnings quality

Operating cash flow
$-1MNo data
Net income
No dataNo data
Free cash flow
$-1MNo data
Diluted EPS
No dataNo data

Cash conversion quality

No data

Per-share economics

Diluted EPS
Latest
No data
FCF / share
Latest
No data
Diluted shares
Latest
No data

Financial flexibility

Cash & equivalents
No dataNo data
Total debt
No dataNo data
Net debt
No dataNo data
Current ratio
No dataNo data

Cash Coverage of Debt

Cash / Total debt
No data

Returns

Return on equity
No dataNo data
Return on assets
No dataNo data
Return on invested capital
No dataNo data
Asset turnover
No dataNo data

Return on capital

No data

Valuation

Price to earnings
No dataNo data
Price to sales
No dataNo data
EV / EBITDA
No dataNo data
Free cash flow yield
No dataNo data

Valuation vs its own 5Y history

Metric
Own five-year range
Current
Own 5Y median
Position in own range
Price to earnings
No data
No data
No data
No data
Price to sales
No data
No data
No data
No data
EV / EBITDA
No data
No data
No data
No data
Free cash flow yield
No data
No data
No data
No data